BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26082558)

  • 1. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
    Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
    Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.
    Perry HM; Oldham SN; Fahl SP; Que X; Gonen A; Harmon DB; Tsimikas S; Witztum JL; Bender TP; McNamara CA
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2771-9. PubMed ID: 24115031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.
    Harmon DB; Srikakulapu P; Kaplan JL; Oldham SN; McSkimming C; Garmey JC; Perry HM; Kirby JL; Prohaska TA; Gonen A; Hallowell P; Schirmer B; Tsimikas S; Taylor AM; Witztum JL; McNamara CA
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):682-91. PubMed ID: 26868208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.
    Kyaw T; Tay C; Krishnamurthi S; Kanellakis P; Agrotis A; Tipping P; Bobik A; Toh BH
    Circ Res; 2011 Sep; 109(8):830-40. PubMed ID: 21868694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.
    Chou MY; Fogelstrand L; Hartvigsen K; Hansen LF; Woelkers D; Shaw PX; Choi J; Perkmann T; Bäckhed F; Miller YI; Hörkkö S; Corr M; Witztum JL; Binder CJ
    J Clin Invest; 2009 May; 119(5):1335-49. PubMed ID: 19363291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auto-Antibody Production During Experimental Atherosclerosis in
    Hutchinson MA; Park HS; Zanotti KJ; Alvarez-Gonzalez J; Zhang J; Zhang L; Telljohann R; Wang M; Lakatta EG; Gearhart PJ; Maul RW
    Front Immunol; 2021; 12():695220. PubMed ID: 34305930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell aortic homing and atheroprotection depend on Id3.
    Doran AC; Lipinski MJ; Oldham SN; Garmey JC; Campbell KA; Skaflen MD; Cutchins A; Lee DJ; Glover DK; Kelly KA; Galkina EV; Ley K; Witztum JL; Tsimikas S; Bender TP; McNamara CA
    Circ Res; 2012 Jan; 110(1):e1-12. PubMed ID: 22034493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-1b Cells Possess Unique bHLH-Driven P62-Dependent Self-Renewal and Atheroprotection.
    Pattarabanjird T; Marshall M; Upadhye A; Srikakulapu P; Garmey JC; Haider A; Taylor AM; Lutgens E; McNamara CA
    Circ Res; 2022 Apr; 130(7):981-993. PubMed ID: 35209718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.
    Upadhye A; Srikakulapu P; Gonen A; Hendrikx S; Perry HM; Nguyen A; McSkimming C; Marshall MA; Garmey JC; Taylor AM; Bender TP; Tsimikas S; Holodick NE; Rothstein TL; Witztum JL; McNamara CA
    Circ Res; 2019 Oct; 125(10):e55-e70. PubMed ID: 31549940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
    Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
    Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Liu E; Peter K; Tipping P; Toh BH; Bobik A; Kyaw T
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with a Toll-like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice.
    Karadimou G; Gisterå A; Gallina AL; Caravaca AS; Centa M; Salagianni M; Andreakos E; Hansson GK; Malin S; Olofsson PS; Paulsson-Berne G
    J Intern Med; 2020 Sep; 288(3):321-334. PubMed ID: 32410352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
    Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
    PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.
    Srikakulapu P; Hu D; Yin C; Mohanta SK; Bontha SV; Peng L; Beer M; Weber C; McNamara CA; Grassia G; Maffia P; Manz RA; Habenicht AJ
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1174-85. PubMed ID: 27102965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine Receptor-6 Promotes B-1 Cell Trafficking to Perivascular Adipose Tissue, Local IgM Production and Atheroprotection.
    Srikakulapu P; Upadhye A; Drago F; Perry HM; Bontha SV; McSkimming C; Marshall MA; Taylor AM; McNamara CA
    Front Immunol; 2021; 12():636013. PubMed ID: 33679793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.
    Schmitz C; Noels H; El Bounkari O; Straussfeld E; Megens RTA; Sternkopf M; Alampour-Rajabi S; Krammer C; Tilstam PV; Gerdes N; Bürger C; Kapurniotu A; Bucala R; Jankowski J; Weber C; Bernhagen J
    FASEB J; 2018 Aug; 32(8):4428-4443. PubMed ID: 29543531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis.
    Rincón-Arévalo H; Castaño D; Villa-Pulgarín J; Rojas M; Vásquez G; Correa LA; Ramírez-Pineda JR; Yassin LM
    Atherosclerosis; 2016 Apr; 247():118-26. PubMed ID: 26897258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.